AIFM2 and cancer: We have developed novel FSP1 inhibitors, such as viFSP [47], the first species-independent FSP1 inhibitor, and icFSP1 [48], which alters intracellular FSP1 localization via phase separation, sensitize various cancer cell lines to ferroptosis.